Scientific Officer, Executive Director BioAgilytix Durham, North Carolina
Join Lynn Kamen and several authors in Poster Forum #7 in the Solution Center for a conversation about posters on the topic, “Advances in Bioanalysis for Evolving Modalities”, that she is especially excited about.
M1430-06-39 A Comprehensive Array of Bioanalytical Assays to Assess the Pharmacokinetic Properties of Antibody-Drug Conjugates In Vivo and In Vitro, Jiaqi Yuan, Ph.D., AstraZeneca
M1330-10-64 Evaluation of In Vitro Protein Binding of STK-001, an Antisense Oligonucleotide, in Plasma and Cerebrospinal Fluid, Qian Lin, B.S., Stoke Therapeutics, Inc.
T1430-06-36 Immunogenicity
Assessment: A Comparative Study between a Chemically Labeled and an Enzymatically Biotinylated rAAV9 Vector, Janey Ronxhi, M.S., Takeda Pharmaceutical Company Limited
T0930-06-40 Optimizing Discovery Bioanalytical Strategy for Macrocyclic Peptides and Degraders with Orbitrap High Resolution Mass Spectrometry, Xing Zhang, Ph.D., Genentech, Inc.
M1330-06-39 Regulatory Perspective of Considerations in Endogenous Therapeutic Analyte Bioanalysis, Chongwoo Yu, Ph.D., US Food and Drug Administration
M1030-06-39 Robust Quantification Method Development for Antisense Oligonucleotide by LC-MS/MS, Sae Wakabayashi, MS, SNBL